Identification of alternative amino acid substitutions in drug-resistant variants of the HIV-1 reverse transcriptase

被引:11
作者
Berkhout, Ben
Back, Nicole K. T.
de Ronde, Anthony
Jurriaans, Suzanne
Bakker, Margreet
Parkin, Neil T.
van der Hoek, Lia
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Human Retrovirol, NL-1105 AZ Amsterdam, Netherlands
[2] Monogram Biosci, San Francisco, CA USA
关键词
drug resistance mutations; evolution; HIV-1; reverse transcriptase;
D O I
10.1097/01.aids.0000237367.56864.75
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective/design: To identify new drug-resistance-associated mutations in the HIV-1 reverse transcriptase (RT) protein, we screened the RT sequence database of our hospital for alternative amino acid substitutions at known RT drug-resistance positions. Method: The genotypic database used for this analysis contained 1322 RT sequences from 1015 patients. We analysed this RT database with a focus on alternative mutations at RT positions known to be involved in drug resistance. The patterns of drug resistance associated with these alternative mutations were investigated in a separate database containing genotype and drug-susceptibility results. Results: We identified multiple alternative resistance-associated mutations at amino acid positions 44, 62, 67, 69, 70, 74, 75, 103, 181, 190, 210, and 219 in RT. Phenotypic analysis indicated that drug-resistance properties of the alternative Y181V and L741 mutants are similar, but not identical, to that of the well-known Y181C and L74V mutations. Conclusion: This initial survey indicates that many resistance-associated phenomena can be distilled from existing data. These findings endorse a more extensive analysis by computerized methods. (c) 2006 Lippincott Williams & Wilkins.
引用
收藏
页码:1515 / 1520
页数:6
相关论文
共 18 条
[1]   HIV-1 evolution under pressure of protease inhibitors: Climbing the stairs of viral fitness [J].
Berkhout, B .
JOURNAL OF BIOMEDICAL SCIENCE, 1999, 6 (05) :298-305
[2]   APOBEC3G versus reverse transcriptase in the generation of HIV-1 drug-resistance mutations [J].
Berkhout, B ;
de Ronde, A .
AIDS, 2004, 18 (13) :1861-1863
[3]   Declining trend in transmission of drug-resistant HIV-1 in Amsterdam [J].
Bezemer, D ;
Jurriaans, S ;
Prins, M ;
van der Hoek, L ;
Prins, JM ;
de Wolf, F ;
Berkhout, B ;
Coutinho, R ;
Back, NKT .
AIDS, 2004, 18 (11) :1571-1577
[4]   RAPID AND SIMPLE METHOD FOR PURIFICATION OF NUCLEIC-ACIDS [J].
BOOM, R ;
SOL, CJA ;
SALIMANS, MMM ;
JANSEN, CL ;
WERTHEIMVANDILLEN, PME ;
VANDERNOORDAA, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (03) :495-503
[5]   Antivirals and antiviral strategies [J].
De Clercq, E .
NATURE REVIEWS MICROBIOLOGY, 2004, 2 (09) :704-720
[6]   Establishment of new transmissible and drug-sensitive human immunodeficiency virus type 1 wild types due to transmission of nucleoside analogue-resistant virus [J].
de Ronde, A ;
van Dooren, M ;
van der Hoek, L ;
Bouwhuis, D ;
de Rooij, E ;
van Gemen, B ;
de Boer, R ;
Goudsmit, J .
JOURNAL OF VIROLOGY, 2001, 75 (02) :595-602
[7]   Extended spectrum of HIV-1 reverse transcriptase mutations in patients receiving multiple nucleoside analog inhibitors [J].
Gonzales, MJ ;
Wu, TD ;
Taylor, J ;
Belitskaya, F ;
Kantor, R ;
Israelski, D ;
Chou, S ;
Zolopa, AR ;
Fessel, WJ ;
Shafer, RW .
AIDS, 2003, 17 (06) :791-799
[8]  
Johnson Victoria A, 2005, Top HIV Med, V13, P125
[9]   Initial appearance of the 184Ile variant in lamivudine-treated patients is caused by the mutational bias of human immunodeficiency virus type 1 reverse transcriptase [J].
Keulen, W ;
Back, NKT ;
vanWijk, A ;
Boucher, CAB ;
Berkhout, B .
JOURNAL OF VIROLOGY, 1997, 71 (04) :3346-3350
[10]   Nucleotide substitution patterns can predict the requirements for drug-resistance of HIV-1 proteins [J].
Keulen, W ;
Boucher, C ;
Berkhout, B .
ANTIVIRAL RESEARCH, 1996, 31 (1-2) :45-57